Chimeric Therapeutics Limited (CHM) operates as a clinical stage cell therapy entity focused on expanding access to cell therapy for patients with cancer. The entity concentrates on the discovery, development, and commercialization of cell therapies through a team experienced in cell therapy research and refinements.
Find out what a historical investment in Chimeric Therapeutics would be worth today using our CHM stock calculator.
Buying CHM shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Chimeric Therapeutics in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in CHM
What is the ticker symbol of Chimeric Therapeutics?
The ticker symbol for Chimeric Therapeutics is CHM.
How much is one share of CHM?
One share of CHM is valued at $0.00 as of 21 November 2026.
What is the market capitalisation of Chimeric Therapeutics CHM?
As of 21 November 2026 Chimeric Therapeutics has a market cap of $440K.
What is the 52-week high for Chimeric Therapeutics stock?
The Chimeric Therapeutics 52-week high stock price is $0.40.
What is the 52-week low for Chimeric Therapeutics stock?
The Chimeric Therapeutics 52-week low stock price is $0.00.
Can I buy CHM shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CHM shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.